BiotechTube
Home/Vividion Therapeutics/Aleksandra Rizo
AR

Aleksandra Rizo

President and Chief Executive Officer

Vividion Therapeutics

Therapeutic Areas

OncologyImmunological Diseases

Vividion Therapeutics Pipeline

DrugIndicationPhase
VVD-214/RO7589831MSI-High CancersPhase 1
KEAP1 Activator ProgramOncologyPhase 1

Leadership Team at Vividion Therapeutics

MP
Matt Patricelli
Chief Scientific Officer
View full Vividion Therapeutics profile